IMI—Global Trends in Myopia Management Attitudes and Strategies in Clinical Practice—2022 Update

角膜塑形术 眼部护理 人气 医学 验光服务 心理干预 地球仪 临床实习 家庭医学 眼科 心理学 护理部 社会心理学 角膜
作者
James S. Wolffsohn,Yasmin Whayeb,Nicola S Logan,Rebecca Weng
出处
期刊:Investigative Ophthalmology & Visual Science [Cadmus Press]
卷期号:64 (6): 6-6 被引量:10
标识
DOI:10.1167/iovs.64.6.6
摘要

Surveys in 2015 and 2019 identified a high level of eye care practitioner concern/activity about myopia, but the majority still prescribed single vision interventions to young myopes. This research aimed to provide updated information.A self-administered, internet-based questionnaire was distributed in 13 languages, through professional bodies to eye care practitioners globally. The questions examined awareness of increasing myopia prevalence, perceived efficacy and adoption of available strategies, and reasons for not adopting specific strategies.Of the 3195 respondents, practitioners' concern about the increasing frequency of pediatric myopia in their practices differed between continents (P < 0.001), being significantly higher in Asia (9.0 ± 1.5 of 10) than other continents (range 7.7-8.2; P ≤ 0.001). Overall, combination therapy was perceived by practitioners to be the most effective method of myopia control, followed by orthokeratology and pharmaceutical approaches. The least effective perceived methods were single vision distance undercorrection, spectacles and contact lenses, as well as bifocal spectacles. Practitioners rated their activity in myopia control between (6.6 ± 2.9 in South America to 7.9 ± 1.2/2.2 in Australasia and Asia). Single-vision spectacles are still the most prescribed option for progressing young myopia (32.2%), but this has decreased since 2019, and myopia control spectacles (15.2%), myopia control contact lenses (8.7%) and combination therapy (4.0%) are growing in popularity.More practitioners across the globe are practicing myopia control, but there are still significant differences between and within continents. Practitioners reported that embracing myopia control enhanced patient loyalty, increasing practice revenue and improving job satisfaction.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Wang发布了新的文献求助10
1秒前
于海阔关注了科研通微信公众号
2秒前
2秒前
力劈华山完成签到,获得积分10
2秒前
顾矜应助流川采纳,获得10
2秒前
量子星尘发布了新的文献求助10
3秒前
顾矜应助毛毛弟采纳,获得10
3秒前
ohh完成签到,获得积分10
3秒前
小团子完成签到 ,获得积分10
4秒前
粉色完成签到,获得积分10
4秒前
4秒前
今后应助追寻的依柔采纳,获得10
5秒前
5秒前
现实的语兰完成签到,获得积分10
5秒前
mumu发布了新的文献求助30
5秒前
6秒前
gzslwddhjx发布了新的文献求助10
7秒前
浮游应助小花采纳,获得10
7秒前
8秒前
8秒前
糊涂的丹南完成签到 ,获得积分10
9秒前
等待的小兔子完成签到,获得积分20
9秒前
lio完成签到,获得积分10
9秒前
酷炫翠桃举报单纯乞求助涉嫌违规
9秒前
香蕉觅云应助江河JT采纳,获得10
10秒前
冷酷的期待完成签到,获得积分10
10秒前
SciGPT应助dablack采纳,获得10
10秒前
俞跃完成签到,获得积分10
10秒前
科研通AI6应助mumu采纳,获得10
11秒前
儒雅雅柏发布了新的文献求助10
12秒前
12秒前
浮游应助可靠白卉采纳,获得10
12秒前
一木完成签到,获得积分10
12秒前
13秒前
burninhell完成签到,获得积分10
13秒前
14秒前
14秒前
Lll发布了新的文献求助10
15秒前
sword完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Acute Mountain Sickness 2000
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
Thomas Hobbes' Mechanical Conception of Nature 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5097188
求助须知:如何正确求助?哪些是违规求助? 4309756
关于积分的说明 13428112
捐赠科研通 4137185
什么是DOI,文献DOI怎么找? 2266508
邀请新用户注册赠送积分活动 1269609
关于科研通互助平台的介绍 1205917